• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2012-2013 年度儿童流感预防与控制建议

Recommendations for prevention and control of influenza in children, 2012-2013.

出版信息

Pediatrics. 2012 Oct;130(4):780-92. doi: 10.1542/peds.2012-2308. Epub 2012 Sep 10.

DOI:10.1542/peds.2012-2308
PMID:22966032
Abstract

The purpose of this statement is to update recommendations for routine use of trivalent seasonal influenza vaccine and antiviral medications for the prevention and treatment of influenza in children. The key points for the upcoming 2012-2013 season are: (1) this year's trivalent influenza vaccine contains A/California/7/2009 (H1N1)-like antigen (derived from influenza A [H1N1] pdm09 [pH1N1] virus); A/Victoria/361/2011 (H3N2)-like antigen; and B/Wisconsin/1/2010-like antigen (the influenza A [H3N2] and B antigens differ from those contained in the 2010-2011 and 2011-2012 seasonal vaccines); (2) annual universal influenza immunization is indicated; and (3) an updated dosing algorithm for administration of influenza vaccine to children 6 months through 8 years of age has been created. Pediatricians, nurses, and all health care personnel should promote influenza vaccine use and infection control measures. In addition, pediatricians should promptly identify influenza infections to enable rapid treatment, when indicated, to reduce morbidity and mortality.

摘要

本声明的目的是更新关于在儿童中常规使用三价季节性流感疫苗和抗病毒药物来预防和治疗流感的建议。即将到来的 2012-2013 季节的要点是:(1) 今年的三价流感疫苗含有 A/加利福尼亚/7/2009(H1N1)样抗原(源自流感 A [H1N1] pdm09 [pH1N1] 病毒);A/Victoria/361/2011(H3N2)样抗原;和 B/Wisconsin/1/2010 样抗原(流感 A [H3N2] 和 B 抗原与 2010-2011 年和 2011-2012 年季节性疫苗中包含的抗原不同);(2) 建议每年普遍进行流感免疫;和 (3) 为 6 个月至 8 岁的儿童制定了更新的流感疫苗接种剂量算法。儿科医生、护士和所有卫生保健人员都应促进流感疫苗的使用和感染控制措施。此外,儿科医生应及时识别流感感染,以便在有指征时进行快速治疗,从而降低发病率和死亡率。

相似文献

1
Recommendations for prevention and control of influenza in children, 2012-2013.2012-2013 年度儿童流感预防与控制建议
Pediatrics. 2012 Oct;130(4):780-92. doi: 10.1542/peds.2012-2308. Epub 2012 Sep 10.
2
Recommendations for prevention and control of influenza in children, 2013-2014.2013-2014 年度儿童流感预防与控制建议
Pediatrics. 2013 Oct;132(4):e1089-104. doi: 10.1542/peds.2013-2377. Epub 2013 Sep 2.
3
Policy statement--recommendations for prevention and control of influenza in children, 2010-2011.政策声明——2010-2011 年度预防和控制儿童流感的建议。
Pediatrics. 2010 Oct;126(4):816-26. doi: 10.1542/peds.2010-2216. Epub 2010 Aug 30.
4
Recommendations for prevention and control of influenza in children, 2011-2012.2011-2012 年度儿童流感预防与控制建议
Pediatrics. 2011 Oct;128(4):813-25. doi: 10.1542/peds.2011-2295. Epub 2011 Sep 2.
5
Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?6至23个月大儿童的流感疫苗免疫原性:启动免疫是否需要相同抗原?
Pediatrics. 2006 Sep;118(3):e570-8. doi: 10.1542/peds.2006-0198.
6
Recommendations for Prevention and Control of Influenza in Children, 2015-2016.2015-2016 年度儿童流感预防与控制建议
Pediatrics. 2015 Oct;136(4):792-808. doi: 10.1542/peds.2015-2920. Epub 2015 Sep 7.
7
Recommendations for Prevention and Control of Influenza in Children, 2017 - 2018.2017-2018 年度儿童流感预防和控制建议
Pediatrics. 2017 Oct;140(4). doi: 10.1542/peds.2017-2550. Epub 2017 Sep 4.
8
Policy statement--recommendations for the prevention and treatment of influenza in children, 2009 -2010.政策声明——2009 - 2010年儿童流感预防与治疗建议
Pediatrics. 2009 Oct;124(4):1216-26. doi: 10.1542/peds.2009-1806. Epub 2009 Sep 7.
9
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011.疫苗预防和控制流感:免疫实践咨询委员会(ACIP)的建议,2011 年。
MMWR Morb Mortal Wkly Rep. 2011 Aug 26;60(33):1128-32.
10
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)--United States, 2012-13 influenza season.疫苗预防和控制流感:免疫实践咨询委员会(ACIP)的建议-美国,2012-13 流感季节。
MMWR Morb Mortal Wkly Rep. 2012 Aug 17;61(32):613-8.

引用本文的文献

1
Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study.与儿童重度流感相关的早期鼻咽微生物特征:一项回顾性试点研究。
J Gen Virol. 2017 Oct;98(10):2425-2437. doi: 10.1099/jgv.0.000920. Epub 2017 Sep 8.
2
Sea buckthorn bud extract displays activity against cell-cultured Influenza virus.沙棘芽提取物对细胞培养的流感病毒具有活性。
J Prev Med Hyg. 2015 Aug 5;56(2):E51-6.
3
Vaccination in children with allergy to non active vaccine components.对非活性疫苗成分过敏的儿童的疫苗接种。
Clin Transl Med. 2015 Feb 14;4:3. doi: 10.1186/s40169-014-0043-0. eCollection 2015.
4
Parental vaccine hesitancy and acceptance of seasonal influenza vaccine in the pediatric emergency department.儿科急诊科家长对季节性流感疫苗的犹豫态度及接受情况
Vaccine. 2015 Apr 8;33(15):1802-7. doi: 10.1016/j.vaccine.2015.02.034. Epub 2015 Mar 2.
5
Guideline on the prevention and control of seasonal influenza in healthcare setting.医疗机构内季节性流感防控指南。
Korean J Intern Med. 2014 Mar;29(2):265-80. doi: 10.3904/kjim.2014.29.2.265. Epub 2014 Feb 27.
6
Influenza vaccination among household contacts of children with cystic fibrosis and healthy children.患有囊性纤维化儿童的家庭接触者与健康儿童的流感疫苗接种情况。
Paediatr Child Health. 2013 Nov;18(9):e55-8.
7
IgA attenuates anaphylaxis and subsequent immune responses in mice: possible application of IgA to vaccines.免疫球蛋白A减轻小鼠过敏反应及后续免疫反应:免疫球蛋白A在疫苗中的可能应用
Immunol Res. 2014 Jan;58(1):106-17. doi: 10.1007/s12026-013-8478-8.
8
Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.体外、小鼠和雪貂模型中 H275Y 奥司他韦耐药甲型 H1N1pdm09 流感病毒潜在允许性神经氨酸酶突变对病毒适应性的影响。
J Virol. 2014 Feb;88(3):1652-8. doi: 10.1128/JVI.02681-13. Epub 2013 Nov 20.
9
Influenza-associated pediatric deaths in the United States, 2004-2012.美国 2004-2012 年与流感相关的儿科死亡病例。
Pediatrics. 2013 Nov;132(5):796-804. doi: 10.1542/peds.2013-1493. Epub 2013 Oct 28.